Disclosure and management of research findings in stem cell research and banking: policy statement

Author:

Isasi Rosario1,Knoppers Bartha M2,Andrews Peter W3,Bredenoord Annelien4,Colman Alan5,Hin Lee Eng6,Hull Sara7,Kim Ock-Joo8,Lomax Geoffrey9,Morris Clive10,Sipp Douglas11,Stacey Glyn12,Wahlstrom Jan13,Zeng Fanyi14,

Affiliation:

1. Center of Genomics & Policy, Faculty of Medicine, Department of Human Genetics, McGill University, Montreal, QC, Canada; Centre of Genomics & Policy, McGill University, QC, Canada.

2. Center of Genomics & Policy, Faculty of Medicine, Department of Human Genetics, McGill University, Montreal, QC, Canada

3. Department of Biomedical Science, University of Sheffield, Sheffield, UK

4. Julius Center, Department of Medical Ethics, University Medical Center Utrecht, Utrecht, The Netherlands

5. Singapore Stem Cell Consortium, Institute of Medical Biology, Singapore

6. Division of Graduate Medical Studies, Faculty of Medicine, National University of Singapore, Singapore

7. NHGRI Bioethics Core, NIH, MD, USA

8. Department of Medical History & Medical Humanities, College of Medicine Seoul National University, Seoul, Korea

9. California Institute for Regenerative Medicine, CA, USA

10. National Health & Medical Research Council, Canberra, Australia

11. Research Unit for Science Policy & Ethics Studies, RIKEN Center for Developmental Biology, Kobe, Japan

12. Division of Cell Biology & Imaging, National Institute for Biological Standards & Control, UK Stem Cell Bank, Potters Bar, UK

13. Department of Medical Genetics, University of Gothenburg, Göteborg, Sweden

14. Shanghai Institute of Medical Genetics, Shanghai Stem Cell Institute, Shanghai, China

Abstract

Prompted by an increased interest of both research participants and the patient advocacy community in obtaining information about research outcomes and on the use of their biological samples; the international community has begun to debate the emergence of an ethical ‘duty’ to return research results to participants. Furthermore, the use of new technologies (e.g., whole-genome and -exome sequencing) has revealed both genetic data and incidental findings with possible clinical significance. These technologies together with the proliferation of biorepositories, provide a compelling rationale for governments and scientific institutions to adopt prospective policies. Given the scarcity of policies in the context of stem cell research, a discussion on the scientific, ethical and legal implications of disclosing research results for research participants is needed. We present the International Stem Forum Ethics Working Party’s Policy Statement and trust that it will stimulate debate and meet the concerns of researchers and research participants alike.

Publisher

Future Medicine Ltd

Subject

Embryology,Biomedical Engineering

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3